Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 7, 2005; 11(37): 5874-5877
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5874
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5874
Table 2 Comparison of IR parameters in NAFLD and control groups
| NAFLD (N: 35) | Controls (N: 34) | P | |
| Fasting insulin (IU/L) | 14.6±6.7 | 9.9±4.5 | <0.01 |
| Insulin 60 min (IU/L) | 99.6±63.1 | 62.4±43.2 | <0.01 |
| Insulin 120 min (IU/L) | 65.3±49 | 40.2±31.9 | <0.01 |
| HOMA index | 3.3±1.5 | 2.1±1.1 | <0.001 |
| Proinsulin (pmol/L) | 10.6±6.4 | 6.2±4.5 | <0.001 |
| C-peptide (ng/mL) | 2.7±0.7 | 2.0±0.6 | <0.001 |
| Adiponectin (mg/mL) | 8.14±3.4 | 12.41±9.4 | <0.01 |
- Citation: Sargin H, Sargin M, Gozu H, Orcun A, Baloglu G, Ozisik M, Seker M, Uygur-Bayramicli O. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? World J Gastroenterol 2005; 11(37): 5874-5877
- URL: https://www.wjgnet.com/1007-9327/full/v11/i37/5874.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i37.5874